TLR3 and coronary artery disorder: Our data support a role for TLR3 in cardiac fibroblasts in contributing to the enhanced inflammatory state and reduced PCDHG expression previously observed in the diseased myocardium of patients with advanced coronary artery disease and aortic valve disease.